live

bselive
nselive

Volume

Todays L/H

Reported Consolidated quarterly numbers for Jubilant Life Sciences are:

Net Sales at Rs 2,374.89 crore in September 2020 up 4.81% from Rs. 2,265.93 crore in September 2019.

Quarterly Net Profit at Rs. 224.03 crore in September 2020 down 10.17% from Rs. 249.39 crore in September 2019.

EBITDA stands at Rs. 493.46 crore in September 2020 up 2.65% from Rs. 480.71 crore in September 2019.

Jubilant Life EPS has decreased to Rs. 14.06 in September 2020 from Rs. 15.66 in September 2019.

Jubilant Life shares closed at 706.30 on November 04, 2020 (NSE) and has given 85.75% returns over the last 6 months and 29.26% over the last 12 months.

Jubilant Life Sciences
Consolidated Quarterly Results	in Rs. Cr.

	Sep'20	Jun'20	Sep'19
Net Sales/Income from operations	2,326.36	1,845.24	2,236.55
Other Operating Income	48.53	47.68	29.38
Total Income From Operations	2,374.89	1,892.92	2,265.93
EXPENDITURE
Consumption of Raw Materials	752.05	610.31	779.10
Purchase of Traded Goods	73.47	57.13	55.40
Increase/Decrease in Stocks	25.06	-47.74	-61.27
Power & Fuel	112.53	96.65	124.80
Employees Cost	558.30	546.39	522.19
Depreciation	115.84	112.30	116.84
Excise Duty	--	--	--
Admin. And Selling Expenses	--	--	--
R & D Expenses	--	--	--
Provisions And Contingencies	--	--	--
Exp. Capitalised	--	--	--
Other Expenses	367.30	327.96	377.26
P/L Before Other Inc., Int., Excpt. Items & Tax	370.34	189.92	351.61
Other Income	7.28	8.13	12.26
P/L Before Int., Excpt. Items & Tax	377.62	198.05	363.87
Interest	63.95	75.95	71.64
P/L Before Exceptional Items & Tax	313.67	122.10	292.23
Exceptional Items	--	--	--
P/L Before Tax	313.67	122.10	292.23
Tax	89.55	34.09	42.84
P/L After Tax from Ordinary Activities	224.12	88.01	249.39
Prior Year Adjustments	--	--	--
Extra Ordinary Items	--	--	--
Net Profit/(Loss) For the Period	224.12	88.01	249.39
Minority Interest	-0.09	--	--
Share Of P/L Of Associates	--	--	--
Net P/L After M.I & Associates	224.03	88.01	249.39
Equity Share Capital	15.93	15.93	15.93
Reserves Excluding Revaluation Reserves	--	--	--
Equity Dividend Rate (%)	--	--	--
EPS Before Extra Ordinary
Basic EPS	14.06	5.53	15.66
Diluted EPS	14.06	5.53	15.66
EPS After Extra Ordinary
Basic EPS	14.06	5.53	15.66
Diluted EPS	14.06	5.53	15.66
Public Share Holding
No Of Shares (Crores)	--	--	--
Share Holding (%)	--	--	--
Promoters and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of shares (Crores)	--	--	--
- Per. of shares (as a % of the total sh. of prom. and promoter group)	--	--	--
- Per. of shares (as a % of the total Share Cap. of the company)	--	--	--
b) Non-encumbered
- Number of shares (Crores)	--	--	--
- Per. of shares (as a % of the total sh. of prom. and promoter group)	--	--	--
- Per. of shares (as a % of the total Share Cap. of the company)	--	--	--
Source : Dion Global Solutions Limited

First Published on Nov 5, 2020 04:22 pm

Jubilant Life Consolidated September 2020 Net Sales at Rs 2,374.89 crore, up 4.81% Y-o-Y

tags #Earnings First-Cut #Jubilant Life #Jubilant Life Sciences #Pharmaceuticals #Results